We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

71 hedge funds and large institutions have $205M invested in Minerva Neurosciences in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 20

0.1% more ownership

Funds ownership: 8.88% → 8.98% (+0.1%)

9% less funds holding

Funds holding: 78 → 71 (-7)

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

29% less capital invested

Capital invested by funds: $290M → $205M (-$85.2M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
71
Holders Change
-7
Holders Change %
-8.97%
% of All Funds
1.77%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
9
Increased
26
Reduced
20
Closed
11
Calls
$83K
Puts
–
Net Calls
+$83K
Net Calls Change
+$83K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$14.7M
2
HCMT
Highland Capital Management (Texas)
Texas
+$12.6M
3
NC
Nexthera Capital
New York
+$2.57M
4
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$1.99M
5
O
OrbiMed
New York
+$1.44M

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$5.2M
2
Millennium Management
Millennium Management
New York
-$4.47M
3
CAM
Cormorant Asset Management
Massachusetts
-$3.34M
4
BBA
Baker Bros. Advisors
New York
-$3.04M
5
EI
EAM Investors
California
-$1.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$402K -$17.5K -225 -3%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$336K +$22.4K +288 +6%
Swiss National Bank
28
Swiss National Bank
Switzerland
$324K – – –
GCP
29
GSA Capital Partners
United Kingdom
$321K +$384K +4,950 New
Goldman Sachs
30
Goldman Sachs
New York
$307K -$109K -1,404 -23%
JP Morgan Chase
31
JP Morgan Chase
New York
$282K -$147K -1,890 -30%
Charles Schwab
32
Charles Schwab
California
$281K – – –
AQR Capital Management
33
AQR Capital Management
Connecticut
$279K -$932 -12 -0.3%
Morgan Stanley
34
Morgan Stanley
New York
$272K -$380K -4,889 -54%
JGC
35
J. Goldman & Co
New York
$269K -$680K -8,760 -68%
TA
36
Teachers Advisors
New York
$253K +$20.7K +267 +7%
AA
37
ALPS Advisors
Colorado
$243K -$34K -438 -10%
CAM
38
ClariVest Asset Management
California
$236K +$2.87K +37 +1%
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$231K – – –
TD Asset Management
40
TD Asset Management
Ontario, Canada
$220K +$3.5K +45 +1%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$212K +$254K +3,267 New
Deutsche Bank
42
Deutsche Bank
Germany
$191K +$116K +1,489 +101%
VEA
43
Virtus ETF Advisers
New York
$169K +$19.3K +249 +11%
ProShare Advisors
44
ProShare Advisors
Maryland
$168K -$51.3K -660 -20%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$161K +$7.69K +99 +4%
CS
46
Credit Suisse
Switzerland
$149K -$118K -1,524 -40%
SCA
47
Secor Capital Advisors
New York
$146K +$175K +2,254 New
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$140K – – –
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$130K +$18.6K +239 +13%
Wells Fargo
50
Wells Fargo
California
$127K – – –
1
2
3 4

NERV Hedge Fund Activity: Q1 2017 in Review

71 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2017, worth a combined $205M — down 29% from $290M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of NERV and 9 opened new positions — a net loss of 2 holders — while 20 trimmed existing stakes and 26 added.

The largest buyer was BlackRock, adding an estimated $14.7M. The largest seller was Marshall Wace, exiting entirely with an estimated $5.2M sold.

  • 71 institutional investors held Minerva Neurosciences (NERV) as of Q1 2017, down from 78 in Q4 2016.
  • Funds reported $205M of Minerva Neurosciences stock for Q1 2017, down 29% quarter-over-quarter.
  • 9 funds opened new Minerva Neurosciences positions in Q1 2017 and 11 closed out, a net change of -2 holders.
  • The largest Minerva Neurosciences buyer in Q1 2017 was BlackRock, an estimated $14.7M added.
  • The largest Minerva Neurosciences seller in Q1 2017 was Marshall Wace, an estimated $5.2M sold.

Based on aggregated 13F filings for Q1 2017.